WallStreetZen

NYSE: ABBV
AbbVie Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ABBV past earnings growth

How has ABBV's earnings growth performed historically?
Company
-22.25%
Industry
22.33%
Market
96.23%
ABBV's earnings have grown slower (0.95% per year) than the US Drug Manufacturers - General industry average (11.67%)
Performance
ABBV's earnings have grown slower (0.95% per year) than the US market average (33.21%)
Performance
ABBV's earnings growth is slowing down - its growth over the last year (-22.25%) is below its 5-year compound annual rate (0.95%)
Performance

ABBV past revenue growth

How has ABBV's revenue growth performed historically?
Company
48.31%
Industry
18.11%
Market
42.59%
ABBV's revenue has grown faster (16.76% per year) than the US Drug Manufacturers - General industry average (5.44%)
Performance
ABBV's revenue has grown slower (16.76% per year) than the US market average (19.59%)
Performance
ABBV's revenue growth is accelerating - its growth over the last year (48.31%) is above its 5-year compound annual rate (16.76%)
Performance

ABBV earnings and revenue history

Current Revenue
$53.7B
Current Earnings
$6.7B
Current Profit Margin
12.4%

ABBV Return on equity

Current Company
48.8%
Current Industry
33.2%
Current Market
23.1%
ABBV's Return on Equity (48.8%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

ABBV Return on assets

Current Company
4.5%
Current Industry
7.3%
ABBV is generating lower Return on Assets (4.5%) than the US Drug Manufacturers - General industry average (7.57%)
Performance

ABBV Return on capital employed

Current Company
7.11%
Current Industry
11.7%
ABBV's ability to generate Return on Capital (7.11%) has decreased compared to 3 years ago (20.54%)
Performance

ABBV earnings dates

Next earnings date
Oct 29, 2021

AbbVie Earnings & Revenue FAQ

What were ABBV's earnings last quarter?

On Invalid Date, AbbVie (NYSE: ABBV) reported Q2 2021 earnings per share (EPS) of $0.42, up 191.3% year over year. Total AbbVie earnings for the quarter were $766.00 million. In the same quarter last year, AbbVie's earnings per share (EPS) was -$0.46.

What was ABBV's earnings growth in the past year?

As of Q4 2021, AbbVie's earnings has grown -22.25% year over year. This is 44.57 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 22.33%. AbbVie's earnings in the past year totalled $6.66 billion.

What is ABBV's earnings date?

AbbVie's earnings date is Invalid Date. Add ABBV to your watchlist to be reminded of ABBV's next earnings announcement.

What was ABBV's revenue last quarter?

On Invalid Date, AbbVie (NYSE: ABBV) reported Q2 2021 revenue of $13.96 billion up 33.9% year over year. In the same quarter last year, AbbVie's revenue was $10.43 billion.

What was ABBV's revenue growth in the past year?

As of Q4 2021, AbbVie's revenue has grown 48.31% year over year. This is 30.21 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 18.11%. AbbVie's revenue in the past year totalled $53.73 billion.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.